↓ Skip to main content

Isolation and Molecular Characterization of Circulating Tumor Cells

Overview of attention for book
Cover of 'Isolation and Molecular Characterization of Circulating Tumor Cells'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Circulating Tumor Cells as Cancer Biomarkers in the Clinic
  3. Altmetric Badge
    Chapter 2 Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells
  4. Altmetric Badge
    Chapter 3 Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics
  5. Altmetric Badge
    Chapter 4 Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors
  6. Altmetric Badge
    Chapter 5 Flow Cytometric Methods for Circulating Tumor Cell Isolation and Molecular Analysis
  7. Altmetric Badge
    Chapter 6 Enrichment and Detection of Circulating Tumor Cells and Other Rare Cell Populations by Microfluidic Filtration
  8. Altmetric Badge
    Chapter 7 Detection and Enumeration of Circulating Tumor Cells with Invasive Phenotype
  9. Altmetric Badge
    Chapter 8 Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures
  10. Altmetric Badge
    Chapter 9 Detection of Gene Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET-Rearrangements in Non-Small-Cell Lung Cancer and ERG-Rearrangements in Prostate Cancer
  11. Altmetric Badge
    Chapter 10 Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells
  12. Altmetric Badge
    Chapter 11 Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells
  13. Altmetric Badge
    Chapter 12 Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer
  14. Altmetric Badge
    Chapter 13 Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells
  15. Altmetric Badge
    Chapter 14 Personalized Treatment Through Detection and Monitoring of Genetic Aberrations in Single Circulating Tumor Cells
  16. Altmetric Badge
    Chapter 15 Glycan Markers as Potential Immunological Targets in Circulating Tumor Cells
  17. Altmetric Badge
    Chapter 16 Significance of EGFR Expression in Circulating Tumor Cells
Attention for Chapter 4: Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors
Altmetric Badge

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors
Chapter number 4
Book title
Isolation and Molecular Characterization of Circulating Tumor Cells
Published in
Advances in experimental medicine and biology, January 2017
DOI 10.1007/978-3-319-55947-6_4
Pubmed ID
Book ISBNs
978-3-31-955946-9, 978-3-31-955947-6
Authors

Carolina Reduzzi, Rosita Motta, Giulia Bertolini, Patrizia Miodini, Antonia Martinetti, Elisa Sottotetti, Maria Grazia Daidone, Vera Cappelletti, Reduzzi, Carolina, Motta, Rosita, Bertolini, Giulia, Miodini, Patrizia, Martinetti, Antonia, Sottotetti, Elisa, Daidone, Maria Grazia, Cappelletti, Vera

Abstract

Genomic characterization of circulating tumor cells (CTCs) enables the monitoring of tumor progression and of adaption occurring during treatment. CTC molecular characterization represents indeed a precious tool to implement in the clinical practice for better dealing with acquired resistance to systemic treatment and tumor evolution. Unfortunately CTCs are very rare and enrichments from blood samples and subsequent identification of these cells are technically very challenging. We describe here the main steps leading to the development of a technical protocol for visualization, enumeration and recovery of single CTCs exploiting the recently developed DEPArray™platform. Our description of the technical workflow starts with evaluation of pre-analytical aspects related to blood sample collection warning about the possible effects on immunoreactivity profiles which may bias the interpretation. Subsequently, other CTC-enrichment approaches are critically discussed and compared in relation to their performances with the DEPArray™. Identification of CTCs represents another critical point due to their heterogeneity and due to the still-to-be clarified role of different subpopulations, typically epithelial, mesenchymal or mixed. Finally, issues related to single cell analysis are illustrated. The chapter ends with an overview of results obtained on real clinical samples which support the reliability of the protocol and its transferability to the daily clinical routine.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 26%
Student > Ph. D. Student 3 16%
Student > Bachelor 2 11%
Student > Doctoral Student 1 5%
Lecturer 1 5%
Other 4 21%
Unknown 3 16%
Readers by discipline Count As %
Medicine and Dentistry 7 37%
Biochemistry, Genetics and Molecular Biology 4 21%
Agricultural and Biological Sciences 1 5%
Chemical Engineering 1 5%
Unknown 6 32%